These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23972946)

  • 1. Evidence for gamma and beta sensory gating deficits as translational endophenotypes for schizophrenia.
    Smucny J; Wylie K; Rojas D; Stevens K; Olincy A; Kronberg E; Zheng L; Tregellas J
    Psychiatry Res; 2013 Nov; 214(2):169-74. PubMed ID: 23972946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximizing the effect of an α7 nicotinic receptor PAM in a mouse model of schizophrenia-like sensory inhibition deficits.
    Stevens KE; Zheng L; Floyd KL; Stitzel JA
    Brain Res; 2015 Jun; 1611():8-17. PubMed ID: 25744161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining CDP-choline and galantamine: Effects of a selective α7 nicotinic acetylcholine receptor agonist strategy on P50 sensory gating of speech sounds in healthy volunteers.
    Choueiry J; Blais CM; Shah D; Smith D; Fisher D; Illivitsky V; Knott V
    J Psychopharmacol; 2019 Jun; 33(6):688-699. PubMed ID: 30920339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensory gating event-related potentials and oscillations in schizophrenia patients and their unaffected relatives.
    Hall MH; Taylor G; Salisbury DF; Levy DL
    Schizophr Bull; 2011 Nov; 37(6):1187-99. PubMed ID: 20363872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining CDP-choline and galantamine, an optimized α7 nicotinic strategy, to ameliorate sensory gating to speech stimuli in schizophrenia.
    Choueiry J; Blais CM; Shah D; Smith D; Fisher D; Labelle A; Knott V
    Int J Psychophysiol; 2019 Nov; 145():70-82. PubMed ID: 30790597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic knockout of the α7 nicotinic acetylcholine receptor gene alters hippocampal long-term potentiation in a background strain-dependent manner.
    Freund RK; Graw S; Choo KS; Stevens KE; Leonard S; Dell'Acqua ML
    Neurosci Lett; 2016 Aug; 627():1-6. PubMed ID: 27233215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectral decomposition of P50 suppression in schizophrenia during concurrent visual processing.
    Moran ZD; Williams TJ; Bachman P; Nuechterlein KH; Subotnik KL; Yee CM
    Schizophr Res; 2012 Sep; 140(1-3):237-42. PubMed ID: 22840844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia.
    Hong X; Chan RC; Zhuang X; Jiang T; Wan X; Wang J; Xiao B; Zhou H; Jiang L; Weng B
    Schizophr Res; 2009 Mar; 108(1-3):151-7. PubMed ID: 19106034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia.
    Zhang XY; Liu L; Liu S; Hong X; Chen DC; Xiu MH; Yang FD; Zhang Z; Zhang X; Kosten TA; Kosten TR
    Am J Psychiatry; 2012 Sep; 169(9):974-81. PubMed ID: 22952075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schizophrenia and the alpha7 nicotinic acetylcholine receptor.
    Martin LF; Freedman R
    Int Rev Neurobiol; 2007; 78():225-46. PubMed ID: 17349863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal beta and gamma frequency neural oscillations mediate auditory sensory gating deficit in schizophrenia.
    Nguyen AT; Hetrick WP; O'Donnell BF; Brenner CA
    J Psychiatr Res; 2020 May; 124():13-21. PubMed ID: 32109667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminating schizophrenia disease progression using a P50 sensory gating task with dense-array EEG, clinical assessments, and cognitive tests.
    Luo Y; Zhang J; Wang C; Zhao X; Chang Q; Wang H; Wang C
    Expert Rev Neurother; 2019 May; 19(5):459-470. PubMed ID: 31111773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensory gating disturbances in the spectrum: similarities and differences in schizotypal personality disorder and schizophrenia.
    Hazlett EA; Rothstein EG; Ferreira R; Silverman JM; Siever LJ; Olincy A
    Schizophr Res; 2015 Feb; 161(2-3):283-90. PubMed ID: 25482574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P50 suppression deficits and psychopathology in Han Chinese patients with schizophrenia.
    Zhu XL; Tan SP; Wang ZR; Zhang JG; Li D; Fan FM; Zhao YL; Zou YZ; Tan YL; Yang F; Zhang XY
    Neurosci Lett; 2017 Jul; 653():346-350. PubMed ID: 28606770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice.
    Adams CE; Yonchek JC; Zheng L; Collins AC; Stevens KE
    Brain Res; 2008 Feb; 1194():138-45. PubMed ID: 18199426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats.
    Hajós M; Hurst RS; Hoffmann WE; Krause M; Wall TM; Higdon NR; Groppi VE
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1213-22. PubMed ID: 15523001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological correlates of P50 sensory gating in patients with schizophrenia.
    Sánchez-Morla EM; Santos JL; Aparicio A; García-Jiménez MÁ; Soria C; Arango C
    Schizophr Res; 2013 Jan; 143(1):102-6. PubMed ID: 23148896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auditory verbal hallucinations in schizophrenia correlate with P50 gating.
    Smith DM; Grant B; Fisher DJ; Borracci G; Labelle A; Knott VJ
    Clin Neurophysiol; 2013 Jul; 124(7):1329-35. PubMed ID: 23490551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does COMT val158met polymorphism influence P50 sensory gating, eye tracking or saccadic inhibition dysfunctions in schizophrenia?
    Demily C; Louchart-de-la-Chapelle S; Nkam I; Ramoz N; Denise P; Nicolas A; Savalle C; Thibaut F
    Psychiatry Res; 2016 Dec; 246():738-744. PubMed ID: 27825784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia.
    Kucinski A; Syposs C; Wersinger S; Bencherif M; Stachowiak MK; Stachowiak EK
    Schizophr Res; 2012 Apr; 136(1-3):82-7. PubMed ID: 22285656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.